CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Company v. Mylan Pharmaceuticals Inc.

1:17-cv-00379

Overview

Case Number 1:17-cv-00379
Filing Date 2017-04-05
Status Terminated
Termination Date 2018-11-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

7 Attorneys Listed

Karen L. Carroll

Email: karencarroll@parkerpoe.com

Micheal L. Binns

Email: michaelbinns@parkerpoe.com

Brandon M. White

Email: BMWhite@perkinscoie.com

Robert L. Florence

Email: robertflorence@parkerpoe.com

Stamatios Stamoulis

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

Melanie B. Dubis

Email: melaniedubis@parkerpoe.com

Sharad K. Bijanki

Email: sharadbijanki@parkerpoe.com

Bristol-Myers Squibb Company NPE (Individual / Inventor)

Represented By

10 Attorneys Listed

Timothy A. Cook

Email: tim.cook@wilmerhale.com

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Andrew J. Danford

Email: andrew.danford@wilmerhale.com

Tracey C. Allen

UNDELIVERABLE EMAIL 6/16/2021

Kevin M. Yurkerwich

Email: kevin.yurkerwich@wilmerhale.com

Heather M. Petruzzi

Email: heather.petruzzi@wilmerhale.com

Jeffrey T. Hantson

Email: jeffrey.hantson@wilmerhale.com

Amy K. Wigmore

Email: amy.wigmore@wilmerhale.com

Pfizer Inc. Operating Company

Represented By

3 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 19 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (19): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2015-08-13
IPR2015-01723

Coalition for Affordable Drugs IX, LLC et al. v. Bristol-Myers Squibb Company

U.S. Continuation Sibling (6967208)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6967208
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
Filed: 2002-09-17
Issued: 2005-11-22
Expiring Soon (140 days) +1665d PTA
Expires: 2027-04-09
US9326945
Apixaban formulations
Filed: 2011-02-24
Issued: 2016-05-03
Active (4.3 yrs remaining)
Expires: 2031-02-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Narrowing Window — Imminent expiration makes injunctive relief unlikely to be granted.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1665 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

16

Dispositive

9

Granted

1

Denied

2

Pending / Review

10

Motions by Category

Procedural / Extension Motion 6 Motion to Dismiss 9 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
MEMORANDUM OPINION re 178 motion to dismiss. Signed by Judge Leonard P. Stark on 10/18/18. Associated Cases: 1:17-cv-00374-LPS, 1:17-cv-00379-LPS (ntl) (Entered...
Entry #69 • 2018-10-18 Document →
Motion to Dismiss Granted
ORDER re (382 in 1:17-cv-00374-LPS, 69 in 1:17-cv-00379-LPS) Memorandum Opinion -- (178 in 1:17-cv-00374-LPS) MOTION to Dismiss or Transfer filed by Mylan Pharm...
Entry #70 • 2018-10-18 Document →
Motion to Dismiss Denied
OPINION re 14 motion to dismiss for improper venue. Signed by Judge Leonard P. Stark on 9/11/17. (ntl) (Entered: 09/11/2017)
Entry #36 • 2017-09-11 Document →
Motion to Dismiss Denied
ORDER re 36 Opinion -- 14 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc. is DENIED. Signed by Judge Leonard P. Stark on 9/11/17. (ntl)...
Entry #37 • 2017-09-11 Document →
Motion to Dismiss Pending / Under Review
[SEALED] REPLY BRIEF re 14 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 08/18/2017)
Entry #25 • 2017-08-18 Document →
Motion to Dismiss Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 14 MOTION to Dismiss for Improper Venue filed by Bristol-Myers Squibb Company, Pfizer Inc..Reply Brief due date per Lo...
Entry #21 • 2017-08-10 Document →

Docket Entries

(144 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116770.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(crb) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116770.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(crb) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116770.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(crb) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116770.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(crb) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116770.) - filed by Bristol-Myers Squibb Company, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(crb) (Entered: 04/06/2017)

Entry #1 • 2017-04-05
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc